Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
RTN-001 by Retension Pharmaceuticals for Hypertension: Likelihood of Approval
RTN-001 is under clinical development by Retension Pharmaceuticals and currently in Phase II for Hypertension. According to GlobalData, Phase II...